(Q41917158)

14 October 2017

title

Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria (English)

1 reference

14 October 2017

0 references

Plasmodium falciparum

0 references

0 references

1 reference

T Harinasuta

1

1 reference

14 October 2017

D Bunnag

2

1 reference

14 October 2017

R Lasserre

3

1 reference

14 October 2017

R Leimer

4

1 reference

14 October 2017

S Vinijanont

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 April 1985

1 reference

14 October 2017

1 reference

14 October 2017

volume

1

1 reference

14 October 2017

issue

8434

1 reference

14 October 2017

page(s)

885-888

1 reference

A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991670-8

7 January 2021

Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991670-8

7 January 2021

Mefloquine (WR 142,490) in the Treatment of Human Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991670-8

7 January 2021

The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991670-8

7 January 2021

10.1016/S0140-6736(85)91670-8

Identifiers

DOI

1 reference

release_rglzzxpclvhtjfpuie3kjqchp4

14 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rglzzxpclvhtjfpuie3kjqchp4

24 November 2022

mapped directly with Wikidata item

1 reference